Opendata, web and dolomites

Miiskin SIGNED

ML-powered app and platform to identify skin changes over time

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Miiskin project word cloud

Explore the words cloud of the Miiskin project. It provides you a very rough idea of what is the project "Miiskin" about.

worldwide    competitive    people    caused    efficient    reduce    thanks    sign       unlocking    clinical    consuming       innovative    lacking    body    bearing    highest    africa    made    artificial    metastases    cancer    melapp    close    2030       position    treatment    automatic    norway    responsible    photo    acquired    market    monitor    232    rate    intelligence    apps    denmark    melanocytes    endorsement    successful    healthcare    innovation    tool    healthy    expansion    patient    globally    treating    250    seal    doctor    node    time    malignant    concentrated    melanoma    quality    diagnosed    detection    poles    australia    risk    miiskin    25    commercial    mortality    south    minimum    monitoring    certification    dermatologically    nevertheless    98    unprecise    app    mm    helping    diagnose    400    mole    mostly    supporting    teledermatology    survival    lymphatic    skinvision    tumour    ambition    deaths    skin    created    countries    identification    moles    originates    manually    spotting    previously   

Project "Miiskin" data sheet

The following table provides information about the project.

Coordinator
MIISKIN APS 

Organization address
address: FRUEBJERGVEJ 3
city: København O
postcode: 2100
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Denmark [DK]
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-12-01   to  2020-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MIISKIN APS DK (København O) coordinator 50˙000.00

Map

 Project objective

Malignant Melanoma (MM) is a tumour which originates mostly in the skin melanocytes and is responsible for most deaths caused by skin cancer, due to the high risk of lymphatic metastases and expansion to other areas of the body. Globally, 232,000 people are diagnosed with MM every year, 90,000 of those concentrated in Europe. While early detection of melanoma has a 98% survival rate, late detection has only a 10-25% survival rate, with a mortality rate going from 3% in countries like Norway or Denmark to 6-7% in other areas close to the poles like South Africa or Australia. Treating MM cost to the healthcare system a minimum of €10,000 to €250,000€ per patient. People at high risk of developing MM or healthy people who has previously been diagnose with MM skin cancer have to regularly monitor their skin and moles for changes. Any skin/mole change can be an early sign of skin cancer and early detection of melanoma is crucial for successful treatment. Nevertheless, the process of spotting manually new changes in the skin can be highly time consuming and unprecise, as it is done manually or using commercial apps (MelApp, SkinVision) lacking clinical certification. We have created, Miiskin app as a supporting tool to help users to monitor skin changes over time with an innovative technology application based in artificial intelligence. Thanks to our innovation, we made the monitoring process more efficient and reliable, helping in the identification of new moles through automatic photo comparison. Moreover, Miiskin will be used as patient-doctor node fully unlocking the potential of teledermatology. Thanks to that we are the unique app worldwide bearing the dermatologically endorsement quality seal. We have already acquired a strong and highly competitive market position as well as the highest rate among Skin Cancer apps, involving more than 400,000 users worldwide. With this ambition we aim to reduce skin cancer mortality to 1% by 2030.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MIISKIN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MIISKIN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

IRMELI (2019)

AI-BASED BROKERING TECHNOLOGY PLATFORM TO FIND THE PERFECT MATCH BETWEEN THE CUSTOMER AND BANK

Read More  

MHS (2019)

Metal Hydrides Hydrogen Storage

Read More  

B2BMarketplace (2019)

The first B2B marketplace for Fast Moving Consumer Goods, connecting all brand manufacturers and retailers globally

Read More